FDA
-
-
-
-
-
-
-
TuHURA Biosciences files IND for TBS-2025 antibody in blood cancers
-
-
-
-
-
-
-
TuHURA names former J&J oncology executive as chief medical officer
-
-
-
-
-
-
-
TuHURA Biosciences Provides Corporate Update Following Recent Financing
-
-
-
-
-
-
-
TuHURA Biosciences (HURA) stock rises following FDA hold lift
-
-
-
-
-
-
-
TuHURA Biosciences, Inc. to Present at the 3rd Annual H.C. Wainwright BioConnect Conference
-
-
-
-
-
-
-
TuHURA Biosciences (HURA) Completes Merger Transaction with Kintara Therapeutics
-
332,014 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

